{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:58:56Z","timestamp":1793242736766,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jneuroim.2017.01.006","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T06:01:20Z","timestamp":1484200880000},"page":"175-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Increased cerebrospinal fluid progranulin correlates with interleukin-6 in the acute phase of neuromyelitis optica spectrum disorder"],"prefix":"10.1016","volume":"305","author":[{"given":"Akio","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3607-0273","authenticated-orcid":false,"given":"Ginette","family":"Serrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Yoshikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Inuzuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2017.01.006_bb0005","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","article-title":"Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17","volume":"442","author":"Baker","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0010","doi-asserted-by":"crossref","first-page":"32298","DOI":"10.1074\/jbc.R112.399170","article-title":"Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration","volume":"287","author":"Cenik","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0015","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1073\/pnas.1017385108","article-title":"Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica","volume":"108","author":"Chihara","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/dvdy.10341","article-title":"Progranulin (acrogranin\/PC cell-derived growth factor\/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development","volume":"227","author":"Daniel","year":"2003","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neulet.2009.12.002","article-title":"Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes","volume":"469","author":"De Riz","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1471-4159.2007.04968.x","article-title":"Progranulin: normal function and role in neurodegeneration","volume":"104","author":"Eriksen","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gutjnl-2011-300643","article-title":"Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism","volume":"61","author":"Frampton","year":"2012","journal-title":"Gut"},{"issue":"1603","key":"10.1016\/j.jneuroim.2017.01.006_bb0040","first-page":"e1","article-title":"Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration","volume":"36","author":"Gibbons","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1189\/jlb.0812429","article-title":"Insights into the role of progranulin in immunity, infection, and inflammation","volume":"93","author":"Jian","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0050","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1016\/j.febslet.2013.09.024","article-title":"Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains","volume":"587","author":"Jian","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0055","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pharmthera.2011.10.003","article-title":"Progranulin: a growth factor, a novel TNFR ligand and a drug target","volume":"133","author":"Liu","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0065","doi-asserted-by":"crossref","first-page":"21260","DOI":"10.1038\/srep21260","article-title":"Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061835","article-title":"Characteristic cerebrospinal fluid cytokine\/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis","volume":"8","author":"Matsushita","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainres.2008.10.021","article-title":"Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injury","volume":"1249","author":"Moisse","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-009-0616-y","article-title":"Progranulin expression is upregulated after spinal contusion in mice","volume":"119","author":"Naphade","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0085","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.tins.2014.04.003","article-title":"Progranulin in neurodegenerative disease","volume":"37","author":"Petkau","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0090","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0095","series-title":"Neuromyelitis Optica Spectrum Disorders. Continuum (Minneap Minn)","first-page":"864","volume":"22","author":"Sand","year":"2016"},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0100","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1186\/bcr3111","article-title":"Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma","volume":"14","author":"Serrero","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0105","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1126\/science.1199214","article-title":"The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice","volume":"332","author":"Tang","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0110","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12031-011-9569-4","article-title":"Structure, function, and mechanism of progranulin; the brain and beyond","volume":"45","author":"Toh","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0115","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1007\/s00415-009-5274-4","article-title":"Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis","volume":"256","author":"Uzawa","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0120","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1177\/1352458511406164","article-title":"Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis","volume":"17","author":"Vercellino","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0125","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1177\/1352458515610646","article-title":"Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis","volume":"22","author":"Vercellino","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0135","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1007\/s10753-014-9911-4","article-title":"Increased serum GP88 (progranulin) concentrations in rheumatoid arthritis","volume":"37","author":"Yamamoto","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.jneuroim.2017.01.006_bb0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.20091568","article-title":"Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice","volume":"207","author":"Yin","year":"2010","journal-title":"J. Exp. Med."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281630337X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281630337X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:30:06Z","timestamp":1759048206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557281630337X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":28,"alternative-id":["S016557281630337X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.01.006","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased cerebrospinal fluid progranulin correlates with interleukin-6 in the acute phase of neuromyelitis optica spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}